IgA deficiency, epilepsy, and phenytoin treatment.

PubWeight™: 2.40‹?› | Rank: Top 2%

🔗 View Article (PMID 52004)

Published in Lancet on October 04, 1975

Authors

J Seager, D L Jamison, J Wilson, A R Hayward, J F Soothill

Articles citing this

IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol (1980) 1.75

Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis. Br Med J (Clin Res Ed) (1983) 1.12

IgA deficiency during D-penicillamine treatment. Br Med J (1977) 1.04

Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol (2003) 0.98

Reduced immunoglobulin concentration and impaired macrophage function in mice due to diphenylhydantoin. Clin Exp Immunol (1978) 0.81

Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy. J Neurol Neurosurg Psychiatry (1978) 0.79

Antibodies to Escherichia coli and serum immunoglobulin levels in epileptics on long-term anticonvulsant therapy. Clin Exp Immunol (1981) 0.79

Immunological study of IgA deficiency during anticonvulsant therapy in epileptic patients. Clin Exp Immunol (1983) 0.78

Epilepsy and allergy. Br Med J (Clin Res Ed) (1981) 0.78

IgA deficiency during treatment of infantile hypothyroidism with thyroxine. Br Med J (Clin Res Ed) (1984) 0.75

Spring meeting, university hospital of wales, cardiff, 1 and 2 april 1977. Arch Dis Child (1977) 0.75

Immunoglobulin A and the kidney. Medical Staff Conference, University of California, San Francisco. West J Med (1982) 0.75

Serum immunoglobulin concentrations in febrile convulsions. Arch Dis Child (1984) 0.75

Association between ABCB1 genetic polymorphism and the effect on epilepsy following phenytoin treatment. Exp Ther Med (2016) 0.75

The effects of phenytoin on T-lymphocyte enumeration [proceedings]. Br J Pharmacol (1977) 0.75

Articles by these authors

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51

Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA (1988) 6.14

Neurological complications of pertussis inoculation. Arch Dis Child (1974) 6.12

The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol (1971) 4.67

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A (1980) 4.66

Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther (1999) 4.65

A double-blind controlled crossover trial of an antigen-avoidance diet in atopic eczema. Lancet (1978) 4.63

The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Hum Reprod (1998) 4.42

Defective opsonization. A common immunity deficiency. Arch Dis Child (1976) 4.20

Transient IgA deficiency and pathogenesis of infantile atopy. Lancet (1973) 4.07

Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet (1983) 3.79

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 3.52

A randomised controlled trial comparing two schedules of antenatal visits: the antenatal care project. BMJ (1996) 3.50

The use of a synthetic medium in the isolation of the somatic antigens of Bact. typhi-murium and Bact. typhosum. Biochem J (1940) 3.45

Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J (1970) 3.38

Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol (1997) 3.24

Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet (1985) 3.09

Differences in immune elimination in inbred mice. The role of low affinity antibody. Clin Exp Immunol (1972) 3.03

Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br (2005) 2.94

Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med (1983) 2.89

Immunological studies in children undergoing tonsillectomy. Clin Exp Immunol (1973) 2.83

Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis (1997) 2.78

Growth in the use of antibiotics in the community in England and Scotland in 1980-93. BMJ (1996) 2.74

Clearing the cataract backlog. Br J Ophthalmol (1987) 2.66

Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG (2012) 2.57

Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma. Lancet (1978) 2.51

Adverse impact of surgical site infections in English hospitals. J Hosp Infect (2005) 2.51

The immunoglobulins in congenital rubella. Lancet (1966) 2.51

Leber's hereditary optic atrophy: a possible defect of cyanide metabolism. Clin Sci (1965) 2.44

Time sequence of acute phase reactive proteins following surgical trauma. Clin Chim Acta (1966) 2.41

Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance. Gut (1979) 2.40

Fc-receptor heterogeneity of human suppressor T cells. J Immunol (1978) 2.37

Chronic granulomatous disease: quantitative clinicopathological relationships. Arch Dis Child (1970) 2.37

Immune exclusion is a function of IgA. Nature (1975) 2.36

Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet (1970) 2.34

Device-related sources of bacteraemia in English hospitals--opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect (2003) 2.33

Food allergy: the major cause of infantile colitis. Arch Dis Child (1984) 2.30

Early recognition of heterozygotes for the gene for dystrophia myotonica. J Neurol Neurosurg Psychiatry (1970) 2.30

The genetic identity of acute infantile spinal muscular atrophy. Brain (1973) 2.26

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25

Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24

Genetic analysis of assembly of the Salmonella enterica serovar Typhimurium type III secretion-associated needle complex. J Bacteriol (2001) 2.24

Narcotic analgesics and delayed gastric emptying during labour. Lancet (1975) 2.24

THE EFFECT OF ARTIFICIAL FEVER AND SPECIFIC ANTISERUM ON THE ORGANISMS PRESENT IN CASES OF TYPE III PNEUMOCOCCUS MENINGITIS. J Clin Invest (1938) 2.24

Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Methods (2001) 2.22

Surface-active biomaterials. Science (1984) 2.21

A defect of the alternative pathway of complement. Clin Exp Immunol (1977) 2.19

Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol (1974) 2.19

Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol (1975) 2.18

Predisposing factors and the development of reaginic allergy in infancy. Clin Allergy (1976) 2.15

Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14

Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol (1978) 2.14

Pertussis vaccine and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 2.13

Inhibition of complement-dependent lymphocyte rosette formation: a possible test for activated complement products. Eur J Immunol (1974) 2.12

Mitochondrial inheritance in a mitochondrially mediated disease. N Engl J Med (1983) 2.08

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07

Serum immune complexes and disease activity in lupus nephritis. Lancet (1977) 2.07

Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (2006) 2.06

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain. J Pain Symptom Manage (2001) 2.06

Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs (1999) 2.05

The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance. Clin Exp Immunol (1972) 2.04

Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03

Dementia and depression among the elderly living in the Hobart community: the effect of the diagnostic criteria on the prevalence rates. Psychol Med (1985) 2.02

Susceptibility-induced loss of signal: comparing PET and fMRI on a semantic task. Neuroimage (2000) 1.97

The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. J Lipid Res (1981) 1.97

Bacterial vaginosis: a public health review. BJOG (2001) 1.95

Induction of plasma cell differentiation of human fetal lymphocytes: evidence for functional immaturity of T and B cells. J Immunol (1977) 1.94

Albumin excretion as a measure of glomerular dysfunction in children. Arch Dis Child (1970) 1.89

Measurement of the rate of nu(e) + d --> p + p + e(-) interactions produced by (8)B solar neutrinos at the Sudbury Neutrino Observatory. Phys Rev Lett (2001) 1.88

Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health (1986) 1.85

Metabolic inter-relationships between cyanide, thiocyanate and vitamin B 12 in smokers and non-smokers. Clin Sci (1966) 1.81

Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation (1982) 1.81

Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80

Mechanisms of the pressor and depressor actions of St 155 (2-(2,6--dichlorophenylamino)-2-imidazoline hydrochloride, Catapres). Eur J Pharmacol (1968) 1.80

Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med (1994) 1.80

Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res (1999) 1.79

Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol (1993) 1.78

Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis. Clin Exp Immunol (1967) 1.78

Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate. J Exp Med (1995) 1.77

A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psychiatry (1986) 1.77

Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res (2001) 1.75

Value of computerised tomography in children with non-specific mental subnormally. Arch Dis Child (1982) 1.74

Serum siderophilin in kwashiorkor. Arch Dis Child (1968) 1.74

HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet (1976) 1.73

Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing. Br Med J (Clin Res Ed) (1981) 1.73

Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res (1981) 1.73

Plasma thiocyanate and vitamin B12 in Nigerian patients with degenerative neurological disease. Lancet (1966) 1.72

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis (1994) 1.71

A test for antigen--antibody complexes in human sera using IgM of rabbit antisera to human immunoglobulins. Clin Exp Immunol (1977) 1.69

Plasma-cobalamins in neuro-ophthalmological diseases. Lancet (1971) 1.68

A feasibility study for a controlled trial of formal psychotherapy. Psychol Med (1972) 1.67

Infant feeding and subsequent risk of atopic eczema. Arch Dis Child (1985) 1.67

Edward Lawrie of the Hyderabad Chloroform Commission. Br J Anaesth (1969) 1.66

Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut (2002) 1.66

A bundle of care to reduce colorectal surgical infections: an Australian experience. J Hosp Infect (2011) 1.65

Inter-mouse strain differences in macrophage function and its relationship to antibody responses. Clin Exp Immunol (1974) 1.65

Some immunological studies of the nephrotic syndrome of Nigerian children. Lancet (1967) 1.65

Association of cystic fibrosis with allergy. Arch Dis Child (1976) 1.64